buyout firms TPG and Pantheon, made commitments through their own secondary investment funds, according to people familiar with the matter and a January regulatory filing in Switzerland.

TPG Capital’s quest to secure a payday at its clinical trials business Novotech is on the home stretch. As reported in December, regional boss Joel Thickins and his advisers at Jefferies ...

SINGAPORE – US private equity firm TPG, through its special purpose vehicle, is looking to take Catalist-listed nursing operator Econ Healthcare (Asia) private by way of a scheme of ...

US private equity firm TPG, through its special purpose vehicle, is looking to take Catalist-listed nursing operator Econ Healthcare (Asia) private by way of a scheme of arrangement, in a near S$88 ...